Q4 2024 CTS Corp Earnings Call Transcript
Key Points
- CTS Corp (CTS) achieved a 28% increase in sales to diversified end markets, including medical, aerospace, defense, and industrial sectors, in the fourth quarter.
- The company reported a 394 basis point improvement in gross margin for the fourth quarter, driven by favorable market mix and operational improvements.
- CTS Corp (CTS) secured multiple wins in electrification, including six E platform wins for accelerator modules, indicating progress in their diversification strategy.
- The SyQwest acquisition contributed $11 million in revenue during the fourth quarter, supporting CTS Corp (CTS)'s growth strategy.
- CTS Corp (CTS) maintained a strong balance sheet with a cash balance of $94 million and generated $99 million in operating cash flow for the full year 2024, up from $89 million in 2023.
- Full-year sales for 2024 were down 6% compared to 2023, with transportation sales declining by 17% due to softness in the China market and competition in the commercial vehicle sector.
- The book-to-bill ratio for the fourth quarter remained at 0.96, indicating potential challenges in future order intake.
- Adjusted diluted earnings per share for the full year 2024 were $2.17, down from $2.22 in 2023, reflecting a decrease in profitability.
- CTS Corp (CTS) anticipates headwinds in transportation revenue in 2025 due to China market dynamics and other regional factors.
- The company expects softness in commercial vehicle revenue throughout 2025, which may impact overall growth prospects.
Hello, everyone and thank you for joining the CTS Corporation fourth quarter and full year 2024 earnings call. My name is Marie and I will be coordinating your call today during the presentation. (Operator Instructions) I will now hand over to your host, Kieran O'Sullivan, Chairman, President and CEO to begin. Please go ahead.
' -
Good morning and thank you for joining us today for our fourth quarter and full year 2024 results. We continue to execute on our diversification strategy to accelerate growth in our diversified medical, industrial aerospace and defense markets while also progressing on electrification in mobility revenue from our diversified markets accounted for 56% of overall company revenue in the fourth quarter and 51% for the full year. 2024.
We had six wins in electrification from our portfolio of existing powertrain agnostic products diversification will continue to be a strategic priority. We expect further progress in 2025 with a full
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
